No Picture
News

Owaves Nearly Doubles Enrollment Target in First Prospective Randomized Clinical Trial with UC San Diego

Nearly 800 UCSD undergraduates enrolled in landmark study evaluating Owaves’ BodyClock AI™ as a preventative, circadian-based intervention for student mood, focus, energy, and flourishing. SAN DIEGO, April 23, 2026 /PRNewswire-PRWeb/ — Owaves, Inc., creator of […]


ADVERTISEMENT — Advertise With Biotech Networks
News

How Does Turbulence Spread?

Researchers observed turbulence in a pure environment without external interference. They discovered a sharp front separating turbulence from non-turbulent fluid, agreeing with earlier theory. However, their data about turbulence decay were not consistent with other […]

No Picture
News

How do astrocytes contribute to fragile X syndrome?

Highlights Salk neuroscientists found how specialized brain cells called astrocytes contribute to fragile X syndrome symptoms They discovered a protein pathway that, when suppressed, can alleviate some symptoms in a mouse model of the syndrome […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

UC San Diego Study Links Diabetes to Early Alzheimer’s-related Changes in the Blood of Latino Adults

Large community study suggests simple blood tests could help identify dementia risk earlier in Latino populations disproportionately affected by diabetes and limited health care access. Click here to view original post Click Here to Publish/Feature […]


ADVERTISEMENT — Advertise With Biotech Networks
News

How can scientists visualize cellular life with greater precision?

Highlights Salk researchers collaborated with scientists at Albert Einstein College of Medicine to develop a new class of probes for imaging living cells The probes, called visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs), generate high-contrast images with […]

No Picture
News

Power Of The Plate Conference Comes to San Diego, May 14-17, 2026, Uniting Global Leaders to Advance the Future of Food, Health, and Sustainability

SAN DIEGO, April 22, 2026 /PRNewswire/ — The Plantrician Project announces the inaugural Power Of The Plate Conference, a global gathering of scientists, clinicians, farmers, policymakers, innovators, and changemakers exploring how food can transform human […]

News

Accelerating Momentum in Clinical Use and Customer Growth for Atraverse Medical’s HOTWIRE™ Transseptal Access System

Data reinforce safety, reduced RF delivery, and consistent performance across workflows; company to showcase system at HRS 2026, Booth 2410 SAN DIEGO, April 22, 2026 /PRNewswire/ — Atraverse Medical, a pioneer in next-generation left-heart access […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Phanes Therapeutics to Present Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting

SAN DIEGO, April 22, 2026 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that they will present updated Phase 2 results of […]

No Picture
News

Anaergia Technologies LLC to Supply Vanguard Renewables with Advanced Anaerobic Digestion Technology

CARLSBAD, California & BURLINGTON, Ontario–(BUSINESS WIRE)–Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG; OTCQX: ANRGF), through its subsidiary Anaergia Technologies LLC (“Anaergia Technologies”), has signed an C$8 million contract with Vanguard Renewables for a follow-up […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer

SAN DIEGO, April 21, 2026 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, today announced updated interim data from its Phase […]

No Picture
News

Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease

SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant […]


ADVERTISEMENT — Advertise With Biotech Networks